1800 975 533 Investing Platform

Investing Platform

Contact us

Call 1800 975 533

or send us a message

This is general advice only and is not an offer, or a solicitation of an offer, to acquire any financial product. Available to wholesale clients only. Registering interest does not commit you to invest — your details are used only to respond to your enquiry. See our Privacy Policy.

The Late Stage 50 · 2026 edition · #50 of 50

OpenEvidence

Our mission is to help doctors save lives and improve patient care.

Access late stageBack to the list
US$100m+Run-rate · Jan 2026
—growth not disclosed
#50rank by disclosed revenue

The figure

Revenue
more than $100 million
Run-rate · Jan 20261CNBC · 21 Jan 2026
In US dollars
US$100m+
as stated
Standing
stated
Named executive on the record — via CNBC
Published
21 Jan 2026
accessed 17 Oct 2026
Evidence
“OpenEvidence said it topped $100 million in annualized revenue last year” — as read on the source page1CNBC · 21 Jan 2026
Prior year
$50 million
Run-rate · Jul 20252Forbes · 20 Oct 2025
Growth
—
not shown: the prior figure is five to six months earlier, not a year.

Context

Founded
2022
3openevidence.com
Headquarters
Miami, United States
3openevidence.com
Sector
Health
Medical AI: clinical-evidence search and decision support for doctors (ad-supported)
IA40 2026
Late · #5
on the list 2× (2025–2026)4IA40 · 19 Oct 2026
Website
www.openevidence.com
Valuation
US$15bn
· as reported, not part of the ranking5Forbes · 30 Sept 2026
Status
Private as of 17 October 2026
Round at $15bn confirmed by the CEO (Forbes, 30 Sep 2026). Business Insider (24 Sep 2026, citing a person familiar with the matter) reported it could be open to selling itself, and may prefer to remain independent; no sale has been announced.6status check · 17 Oct 2026

Investing Platform

Late-stage access for wholesale investors.

Investing Platform presents late-stage private companies to wholesale investors. This profile is a factual reference and not an offer.

See late stage on Investing Platform
← #49 Skild AI Back to the list

References

Every figure on this page, by source.

  1. 1CNBC · 21 Jan 2026www.cnbc.com/2026/01/21/openevidence-chatgpt-for-doctors-doubles-valuation-to-12-billion.h…
  2. 2Forbes · 20 Oct 2025web.archive.org/web/20251214145948/https://www.forbes.com/sites/amyfeldman/2025/10/20/open…
  3. 3openevidence.comwww.openevidence.com/about
  4. 4IA40 · 19 Oct 2026www.ia40.com/the-list/
  5. 5Forbes · 30 Sept 2026web.archive.org/web/20261002214333/https://www.forbes.com/sites/saibala/2026/09/30/openevi…
  6. 6status check · 17 Oct 2026www.businessinsider.com/chatgpt-for-medicine-openevidence-fielding-valuation-2026-9

Every link was opened on 17 October 2026 and the figure read on the page. Secondary-market indications, where shown, are provided by Forge Global and Clarity (formerly Hiive), are not offers, and play no part in the ranking.